Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

29

Revenue 2017

Soliris

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Soliris was produced by Alexion.

Analysts question value of rumoured $20bn Roche bid for Alexion

Analysts question value of rumoured $20bn Roche bid for Alexion Alexion currently has one drug on the market in the form of Soliris (eculizumab), a treatment for the rare blood disorder paroxysmal nocturnal haemoglobinuria (PNH) and atypical haemolytic uraemia syndrome (aHUS). ... Soliris has just been granted orphan

Alexion begins work on new global headquarters

Alexion begins work on new global headquarters Sales of its lead terminal complement inhibitor Soliris (eculizumab) last year topped $1.1bn and asfotase alfa, its treatment for the inherited metabolic disorder hypophosphatasia that last month received breakthrough status

FDA gives Alexion's metabolic drug breakthrough status

FDA gives Alexion's metabolic drug breakthrough status Alexion focuses its attention on rare diseases, and has already chalked up one success with its Soliris (eculizumab) product, a first-in-class terminal complement inhibitor that is approved for the ... Soliris sales topped $1.1bn in 2012, a 45 per cent

[ Previous 5 results ] 2 3 4 5 6

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics